Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Jun 17, 2016
Insider Transaction Report
Form 4
Celniker Abbie
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-06-15+30,024→ 30,024 totalExercise: $0.28From: 2016-06-15Exp: 2026-02-24→ Common Stock (30,024 underlying)
Footnotes (1)
- [F1]On February 25, 2016, the reporting person was granted an option to purchase 90,000 shares of common stock. This option vests in installments based on the achievement of certain regulatory and business milestones. The Compensation Committee of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 30,024 shares.